Agilon Health Inc (AGL) Shares See 26.56% Rise Over Last Week

At the time of writing, Agilon Health Inc [AGL] stock is trading at $2.43, up 10.96%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AGL shares have gain 26.56% over the last week, with a monthly amount glided 8.48%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup upgraded its rating to a Neutral and also boosted its price target to $2.25 from $1.75. On December 16, 2024, Macquarie initiated with a Neutral rating. Bernstein started tracking the stock assigning a Mkt Perform rating and suggested a price target of $2.50 on December 11, 2024. JMP Securities downgraded its rating to a Mkt Perform. William Blair downgraded its rating to Mkt Perform for this stock on November 08, 2024. In a note dated October 30, 2024, Citigroup downgraded an Sell rating on this stock and revised its target price from $7 to $2.50.

For the past year, the stock price of Agilon Health Inc fluctuated between $1.50 and $9.30. Currently, Wall Street analysts expect the stock to reach $3.17 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $2.43 at the most recent close of the market. An investor can expect a potential return of 30.45% based on the average AGL price forecast.

Analyzing the AGL fundamentals

According to Agilon Health Inc [NYSE:AGL], the company’s sales were 5.59B for trailing twelve months, which represents an 19.35% jump. Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.5 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.20 points at the first support level, and at 1.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.62, and for the 2nd resistance point, it is at 2.82.

Ratios To Look Out For

It is important to note that Agilon Health Inc [NYSE:AGL] has a current ratio of 1.29. Further, the Quick Ratio stands at 1.29, while the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 0.18, the price to book ratio is 1.74.

Transactions by insiders

Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.

Related Posts